Vickers Philip J. 4
4 · Revance Therapeutics, Inc. · Filed Mar 16, 2018
Insider Transaction Report
Form 4
Vickers Philip J.
Director
Transactions
- Purchase
Common Stock
2018-03-16$31.25/sh+2,250$70,313→ 5,250 total - Purchase
Common Stock
2018-03-16$31.20/sh+900$28,080→ 6,150 total